We typically consider post op SBRT for previously irradiated lesions, radioresistant histologies (renal cell, melanoma, sarcoma, GI primaries, for example), or patients with good prognosis (oligometastatic for example). These patients will have excellent and durable tumor control, low risk of toxic...